drugset / Trial / NCT03299842

A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

NCT03299842

Phase 3 Terminated 5 enrolled Zogenix, Inc.
NaSingle-groupOpen-labelTreatment

Summary

This is an exploratory sub-study to ZX008-1503 \[NCT02823145\]. Subjects will be fitted with an Embrace seizure detection watch and seizures detected by the watch will be compared to those entered into an electronic seizure diary.

Timeline

Start
2017-07-12
Primary completion
2018-07-05
Completion
2018-07-05

Drugs

EvaluationDrugModalityDoseRoute
Background Fenfluramine Small molecule 0.2 mg/kg Oral

Indications